Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Since 2020, COVID-19 has surged across the nation and the world. With variants like Omicron, Delta, Alpha and more, this ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

particularly in the setting of evolving variants and pre-existing immunity. Two studies presented at this year's IDWeek ...

KP.3 was the 'predominant' SARS-CoV-2 variant in the US. It was also spreading in Europe. It's now joined with another ...

There have been many different types of variants and subvariants of Covid since the pandemic began as the virus continues to change. Alpha, Beta, Delta, Omicron, FliRT and FLuQE saw cases surge ...

LTV is more effective than NTV and ETV against Mpro mutants, making it a promising candidate for treating drug-resistant ...

The company is focusing on respiratory vaccines, including RSV, Flu, and COVID-19 variants, to sustain and grow its revenue streams. Despite massive R&D expenditures and significant losses ...

Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming ...

Moderna (NASDAQ:MRNA) shares traded in the green on Friday, snapping six consecutive days of losses. The stock closed up 0.55 ...